Caliper Life Sciences Up 7.3% On Preliminary Results (CALP)

Shares of Caliper Life Sciences Inc. CALP are trading up 7.3% at $6.05 per share during the Thursday afternoon trading session. On Thursday morning before the market opened, the company announced preliminary 4th quarter revenue results of $36.0 million, which exceeded the upper end of its previous revenue guidance by about $2.5 million. The day's range for shares of Caliper Life Sciences Inc has been between $5.70 and $6.17 per share. The average price target of analysts who cover Caliper Life Sciences Inc. (CALP) is $8.00 per share. Volume of 192,000 shares is is still below the daily average volume of 241,000 shares. Caliper Life Sciences Inc. (CALP) is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. Read more from Benzinga's Company news.